The FDA has recalled multiple lots of a blood pressure medication sold under the brand name Ziac, according to a Dec. 6 report from USA Today.
The medication — bisoprolol fumarate and hydrochlorothiazide tablets — is manufactured by Glenmark Pharmaceuticals and may have been cross-contaminated with cholesterol drug ezetimibe, the report said.
The Class III recall affects 2.5-mg to 6.25-mg dosages from the following lots, according to USA Today:
- 30-tablet bottles, NDC-68462-878-30. Lot 17232401, exp. 11/2025.
- 100-tablet bottles, NDC-68462-878-01. Lot 17232401, exp. 11/2025.
- 500-tablet bottles, NDC-68462-878-05. Lot 17232401, exp. 11/2025
- 500-tablet bottles, NDC-68462-878-05. Lot 17240974, exp. 05/2026.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
